Company intelligence / Profile preview

SW Partners

Not disclosed (likely United States or Europe, based on founder background and activity)

Ownership: Private
Development stage: Other

Overview

SW Venture Partners (Sea Wolves Venture Partners) provides scientific/corporate due diligence, C-suite management, and early-stage company creation services in antibody therapeutics, cell therapy, and mRNA technologies. No direct clinical results; instead, enables clinical innovation via portfolio companies

Therapeutic areas: Other
Modalities: AntibodyCell therapymRNA-based drugs
Industry: Investors

Partnerships

Seeking co-investors for portfolio companies; specific names not disclosed

Beyond the preview

Go deeper on SW Partners.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on SW Partners.

Explore the full profile